Prescription drug · NDA
Visipaque (Iodixanol) NDC 0407-2223
Iodixanol 320 mg/mL · Injection, Solution · Intravascular · GE Healthcare Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0407-2223-23 | 00407222323 | 10 BOTTLE, PLASTIC in 1 BOX (0407-2223-23) / 500 mL in 1 BOTTLE, PLASTICMarketed from May 1, 2006 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Visipaque
- Generic name (nonproprietary)
- iodixanol
- Active ingredients
- Iodixanol — 320 mg/mL
- Dosage form
- Injection, Solution
- Route
- Intravascular
- Labeler
- GE Healthcare Inc.NDC labeler code 0407
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 020808
- Marketing start
- Listing expires
- Other FDA classes
- X-Ray Contrast Activity (Mechanism)
- Identifiers
- Product ID 0407-2223_dfc406b7-c140-4092-9cc5-9677b8097a80SPL ID dfc406b7-c140-4092-9cc5-9677b8097a80SPL set ID 2d964c13-88ad-43be-88d4-a3a7ea4d5b5eUNII HW8W27HTXX
- Pharmacologic class
- Radiographic Contrast Agent
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N400407222323followed by a unit qualifier and the quantityPackage 00407-2223-23. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
VISIPAQUE is indicated for: VISIPAQUE injection is a radiographic contrast agent indicated for the following: Intra-arterial Procedures ( 1.1 ) Adults and pediatric patients 12 years of age and over Intra-arterial digital subtraction angiography (270 and 320 mg Iodine/mL). Angiocardiography (left ventriculography and selective coronary arteriography), peripheral arteriography, visceral arteriography, and cerebral arteriography (320 mg Iodine/mL). Pediatric patients less than 12 years of age Angiocardiography, cerebral arteriography, and visceral arteriography (320 mg Iodine/mL). Intravenous Procedures ( 1.2 ) Adults and pediatric patients 12 years of age and over Computed tomography (CT) ima…
Excerpt only. Read the full label for complete information.
About NDC 0407-2223
- What is NDC 0407-2223?
- 0407-2223 is the product NDC for Visipaque (iodixanol), Iodixanol 320 mg/mL injection, solution, listed with the FDA by GE Healthcare Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Visipaque (Iodixanol).
- What is the active ingredient?
- Iodixanol.
- Who is the labeler?
- GE Healthcare Inc., NDC labeler code 0407. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Visipaque?
- 1 other product NDC are listed under this name. See all Visipaque NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Visipaque products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Visipaqueiodixanol | Iodixanol 270 mg/mL | Injection, SolutionIntravascular | GE Healthcare Inc. | 0407-2222 | 00407-2222-1600407-2222-1700407-2222-19+1 more |